Chief Scientific Officer, Daniel Galbraith writes on the fast growing Biosimilar market, published in Industry Voices section by FierceBiotech. Read the article here.
BioOutsource Launches Comprehensive Range of Off-the-Shelf Testing Methodologies to Support Biosimilar Characterisation & Comparability Testing
Expands Glasgow, Scotland Testing Facilities and Ramps up Commercial Activities in US and Asia-Pacific GLASGOW, Scotland – September 20, 2013 – BioOutsource Ltd. (“BioOutsource”), a leading international Contract Testing Organization (CTO) has consolidated its position as the leading expert in the biological analysis of Biosimilar Monoclonal Antibodies for the biopharmaceutical industry. Strategic internal R&D investment More